Chi Sheng Pharma & Biotech Co., Ltd (4111.TWO)

TWD 27.7

(2.59%)

Long Term Debt Summary of Chi Sheng Pharma & Biotech Co., Ltd

  • Chi Sheng Pharma & Biotech Co., Ltd's latest annual long term debt in 2023 was - TWD , down -100.0% from previous year.
  • Chi Sheng Pharma & Biotech Co., Ltd's latest quarterly long term debt in 2024 Q2 was 3.81 Million TWD , down 0.0% from previous quarter.
  • Chi Sheng Pharma & Biotech Co., Ltd reported annual long term debt of 2.27 Million TWD in 2022, down -68.77% from previous year.
  • Chi Sheng Pharma & Biotech Co., Ltd reported annual long term debt of 7.28 Million TWD in 2021, up 3.5% from previous year.
  • Chi Sheng Pharma & Biotech Co., Ltd reported quarterly long term debt of 3.81 Million TWD for 2024 Q2, down 0.0% from previous quarter.
  • Chi Sheng Pharma & Biotech Co., Ltd reported quarterly long term debt of 889 Thousand TWD for 2023 Q3, down -29.16% from previous quarter.

Annual Long Term Debt Chart of Chi Sheng Pharma & Biotech Co., Ltd (2023 - 2019)

Historical Annual Long Term Debt of Chi Sheng Pharma & Biotech Co., Ltd (2023 - 2019)

Year Long Term Debt Long Term Debt Growth
2023 - TWD -100.0%
2022 2.27 Million TWD -68.77%
2021 7.28 Million TWD 3.5%
2020 7.03 Million TWD -21.63%
2019 8.98 Million TWD 0.0%

Peer Long Term Debt Comparison of Chi Sheng Pharma & Biotech Co., Ltd

Name Long Term Debt Long Term Debt Difference
St.Shine Optical Co.,Ltd. 316.84 Million TWD 100.0%
Bioteque Corporation 446.23 Million TWD 100.0%
Sunder Biomedical Tech. Co., Ltd. 228.34 Million TWD 100.0%
BenQ Medical Technology Corporation 843.13 Million TWD 100.0%
Pacific Hospital Supply Co., Ltd 418.88 Million TWD 100.0%
Unicon Optical Co., Ltd. 135.28 Million TWD 100.0%
Formosa Optical Technology Co.,Ltd. 1.03 Billion TWD 100.0%
Medeon Biodesign, Inc. - TWD NaN%
Concord Medical Co., Ltd. 183.62 Million TWD 100.0%
Crystalvue Medical Corporation 19.01 Million TWD 100.0%
Perfect Medical Industry Co., Ltd. 45.22 Million TWD 100.0%
ICARES Medicus, Inc. 102.63 Million TWD 100.0%
Lagis Enterprise Co., Ltd. 155 Million TWD 100.0%
Amed Co., Ltd. 145.41 Million TWD 100.0%